Medical News

RSS

Autism discrimination case at Perth Methodist college

A Perth girl’s school admitted to discriminating against an autistic pupil who was denied a trained aide. This made her lose nine months of schooling. Methodist Ladies College in Perth’s wealthy western suburbs in a first of its kind case in Australia was forced to apologise to parents Andrew and Mandy Mason after they took the school to the Federal Court and secured a settlement in their favour.

22 Dec 2010

Snowblowers can cause severe hand injuries during winter

It's the peak season for snowstorms, and snowblowers are working overtime. But Loyola University Health System hand surgeon Dr. Randy Bindra cautions that snowblowers can cause severe hand injuries, including loss of fingers that can require one or more surgeries and months of rehabilitation.

22 Dec 2010

Millennia compiles data on 100 wounds treated with Cytomedix AutoloGel System

Cytomedix, Inc. a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis, today announced that its Japanese partner, Millennia Holdings, Inc. ("Millennia"), has compiled data on 100 wounds treated with the Company's AutoloGel™ System, and will use this initial data to support its regulatory and reimbursement filings in Japan. The full data set is expected to be released through presentations at scientific and medical meetings and through publication in a peer-reviewed journal.

22 Dec 2010

Arena, Eisai complete lorcaserin NDA end-of-review meeting with FDA

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today the completion of an end-of-review meeting with the US Food and Drug Administration (FDA) for the lorcaserin New Drug Application (NDA).

22 Dec 2010

Delcath completes NDA submission for chemosaturation system

Delcath Systems, Inc. today announced that the Company has submitted the remaining modules of its 505(b)(2) New Drug Application (NDA) for its proprietary chemosaturation system to the U.S. Food & Drug Administration (FDA). The Company had previously submitted Module 4, consisting of literature based non-clinical data, to the FDA in late April 2010. The Company is seeking an indication for the percutaneous intra-arterial administration of melphalan hydrochloride for use in the treatment of patients with metastatic melanoma in the liver.

22 Dec 2010

Walgreen first quarter sales increase 6.0% to record $17.3 billion

Walgreens announced record earnings and sales for the first quarter of fiscal year 2011.

22 Dec 2010

Seaside purchases additional $2.5M of NanoViricides' Series B Convertible Preferred Stock

NanoViricides, Inc., announced today that it had consummated a closing with Seaside 88, LP ("Seaside"), a Florida limited partnership, on Seaside's purchase of an additional $2.5M of the Company's Series B Convertible Preferred Stock. Seaside has financed several leading-edge bio-pharma companies, including Cytori Therapeutics, Inc., Generex Biotechnology Corporation, and NovaDel Pharma, Inc. among others.

22 Dec 2010

Centric Health to acquire certain assets of DNPI Group subject to Court approval

Centric Health Corporation, Canada's leading diversified healthcare services company, today announced that it has entered into an agreement ("APA") to acquire certain assets of Dedicated National Pharmacies Inc., Methadrug Clinic Limited and Union Medical Pharmacy Inc. ("DNPI Group") from the court-appointed receiver of the DNPI Group, Grant Thornton Limited (the "Receiver").

22 Dec 2010

NIH Clinical Center opens doors to Damon Runyon Clinical Investigators

A new pilot partnership between the National Institutes of Health Clinical Center, the National Cancer Institute's Center for Cancer Research, and the Damon Runyon Cancer Research Foundation will offer some of the capabilities and expertise of America's research hospital to an external group of clinical investigators in cancer research. The special talent and resources of the NIH will allow Damon Runyon-funded investigators to undertake studies and collaborations that will advance understanding of the prevention, diagnosis, and treatment of cancer.

22 Dec 2010

Earlier ART initiation should be highest priority for global expansion of HIV patient care

Earlier initiation of antiretroviral therapy should be the highest priority for global expansion of HIV patient care. This finding, from a paper published in this week's PLoS Medicine, should help resource-limited nations to phase in the implementation of the new 2010 WHO recommendations for HIV treatment. "Immediate scale-up of the entire WHO guideline package may be prohibitively expensive in some settings," said lead author Rochelle P. Walensky, MD, MPH of the Massachusetts General Hospital, Boston, USA.

22 Dec 2010

Edge releases edgeDMS for iPad for Dentists and Dental offices

Edge EHR Corp., EDGE, a provider of Dental Practice Management solutions for the Mac OS®, is pleased to announce the release of edgeDMS™ for iPad® for Dentists and Dental offices looking to leverage the awesome power of the Apple® iPad.

22 Dec 2010

Vote For Kids Health calls for voting support to help win December Pepsi Refresh Project

Critically ill and disadvantaged children are counting on the generosity of strangers Thursday, December 23, 2010, asking for 100,000 votes to help win their grant ideas in the December Pepsi Refresh Project. Securing the thousands of votes needed to finish in winning spots is an uphill challenge for many organizations, but eight enterprising charities have joined forces to help each other into the winners circle.

22 Dec 2010

USPTO terminates interference proceeding in favor of PDL's '089 Patent

PDL BioPharma, Inc. today announced that on December 15, 2010, the U.S. Patent and Trademark Office (the PTO) terminated its interference proceeding between certain claims of the Company's Queen et al., U.S. Patent No. 5,585,089, (the '089 Patent) and certain pending claims of Adair et al., U.S. Application No. 08/846,658, (the '658 Application) in favor of the Company's '089 Patent.

22 Dec 2010

NAHN and Partnership at Drugfree.org join to address teen drug and alcohol use in the Hispanic community

The Partnership at Drugfree.org today announced a new strategic partner to help support the organization's outreach to address teen drug and alcohol use within the Latino and Spanish-speaking community and equip Hispanic parents with tools from prevention to treatment of drug and alcohol abuse. The National Association of Hispanic Nurses (NAHN) has joined with the national nonprofit to provide bilingual resources to Spanish-speaking parents and caregivers and help promote the group's online tools and resources across various NAHN communication channels.

22 Dec 2010

ACSF releases report on EPA's new pollution controls for electric power plants

The American Clean Skies Foundation (ACSF) released a new report today on the plans of the Environmental Protection Agency (EPA) to adopt stricter pollution controls for electric power plants. The report concludes that the EPA's proposed actions are likely to spur major changes in the fuels used by the utility sector -- with greater reliance on cleaner sources such as natural gas and renewable energy -- and should not present reliability concerns.

22 Dec 2010

Excessive carbohydrates, rather than fat, may be the source of America's dietary woes

A growing number of top nutritional scientists are pointing to excessive carbohydrates, rather than fat, as the source of America's dietary woes. As reported in the Los Angeles Times on December 20, some researchers are saying that cutting carbohydrates is the key to reversing obesity, heart disease, Type 2 diabetes and hypertension.

22 Dec 2010

First Edition: December 22, 2010

Today's headlines include a number of reports regarding a new proposed rule by the Department of Health and Human Services that will require insurers to justify large premium hikes.

22 Dec 2010

FDA issues CRL to Cumberland's Acetadote sNDA for non-acetaminophen acute liver failure

Cumberland Pharmaceuticals Inc. announced today that it has received a Complete Response Letter from the U.S. Food and Drug Administration (FDA) regarding its supplemental new drug application (sNDA) for Acetadote® (acetylcysteine) Injection to treat patients with non-acetaminophen induced acute liver failure.

22 Dec 2010

BioCryst commences BCX4208/allopurinol combination Phase 2b study in gout patients

BioCryst Pharmaceuticals, Inc. announced the initiation of a Phase 2b study of BCX4208 as add-on therapy in gout patients who have not responded to allopurinol therapy alone.

22 Dec 2010

Red Cross and Pitney Bowes deliver 'a touch of home' to service members, veterans

Hundreds of thousands of holiday cards are beginning to arrive at military bases and hospitals around the world, as American Red Cross workers deliver the handiwork and heartfelt wishes collected through this year's Holiday Mail for Heroes campaign.

22 Dec 2010

Medical News

Autism discrimination case at Perth Methodist college

Snowblowers can cause severe hand injuries during winter

Millennia compiles data on 100 wounds treated with Cytomedix AutoloGel System

Arena, Eisai complete lorcaserin NDA end-of-review meeting with FDA

Delcath completes NDA submission for chemosaturation system

Walgreen first quarter sales increase 6.0% to record $17.3 billion

Seaside purchases additional $2.5M of NanoViricides' Series B Convertible Preferred Stock

Centric Health to acquire certain assets of DNPI Group subject to Court approval

NIH Clinical Center opens doors to Damon Runyon Clinical Investigators

Earlier ART initiation should be highest priority for global expansion of HIV patient care

Edge releases edgeDMS for iPad for Dentists and Dental offices

Vote For Kids Health calls for voting support to help win December Pepsi Refresh Project

USPTO terminates interference proceeding in favor of PDL's '089 Patent

NAHN and Partnership at Drugfree.org join to address teen drug and alcohol use in the Hispanic community

ACSF releases report on EPA's new pollution controls for electric power plants

Excessive carbohydrates, rather than fat, may be the source of America's dietary woes

First Edition: December 22, 2010

FDA issues CRL to Cumberland's Acetadote sNDA for non-acetaminophen acute liver failure

BioCryst commences BCX4208/allopurinol combination Phase 2b study in gout patients

Red Cross and Pitney Bowes deliver 'a touch of home' to service members, veterans

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News